COLGATE PALMOLIVE CO CL

Colgate-Palmolive's strongest current fact is not a rumour or a price squiggle. It is the latest SEC 10-Q for the period ending 2026-03-31, which reports revenue from contracts with customers, excluding assessed tax, of $5.32B, operating income of $964.0M, net income attributable to parent of $646.0M and diluted EPS of $0.80. The accompanying 8-K says the company issued its quarter-ended March 31, 2026 earnings press release on May 1, 2026.

The supplied product rail shows an operating business built around Oral, Personal and Home Care products, with brands marketed at multiple price points. That matters because the filing itself names the consumer pressure point: even with significant resources devoted to brand support and marketing, demand and sales volumes may decline or shift from higher margin to lower margin product offerings. The company is not only selling categories people recognise. It is managing the price, volume and margin mix inside those categories.

The segment detail is the useful pulse reading. Net sales in the Oral, Personal and Home Care product segment were $4,131 in the first quarter of 2026, up 8.9% from the first quarter of 2025, with volume growth of 1.3%, net selling price increases of 1.8% and positive foreign exchange of 5.9%. Organic sales in that same segment increased 3.1%. The broader filing line also shows assets of $16.61B, liabilities of $16.12B, stockholders' equity attributable to parent of $145.0M, cash and equivalents of $1.33B, operating cash flow of $747.0M, inventory of $2.09B and a $41.0M increase in inventories for the 2026-03-31 period.

No chart route is supplied in the evidence, so this report cannot name price levels, moving averages, support, resistance or candle behaviour. The market mechanism available here is the SEC filing rail: the 10-Q, the May 1 8-K, the SEC EDGAR filing index, the SEC submissions JSON and the SEC companyfacts JSON. That is enough to describe earnings, balance-sheet pressure, segment sales drivers and source limits, but not enough to claim what the share price has done intraday.

The named public developments are all SEC EDGAR events: a Form 4 on 2026-06-17, a Form 3 on 2026-06-05, an SD filing on 2026-06-01, a Form 4 on 2026-05-18 and two Form 4 filings on 2026-05-13. Those filings matter as governance and disclosure events, but the supplied rail does not parse the transaction details inside them. The honest read is therefore precise and narrow: earnings and product economics are visible, while insider-reporting detail needs the underlying filing fields before it can carry a stronger claim.

The current tension sits between a plainly cash-generative consumer-products business and a filing that admits demand can shift towards lower margin offerings. The Board's April 30, 2026 expansion of the Strategic Growth and Productivity Program, disclosed in the May 1 8-K, adds another concrete item to follow. It does not prove future savings or growth by itself. It proves management has widened a programme originally approved on July 31, 2025 to support the company's 2030 strategy.